Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. (Q34580135)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kanneboyina Nagaraju

4

object named as

Kanneboyina Nagaraju

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Toshifumi Yokota

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Emidio Pistilli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

1 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Expert Opinion on Biological Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

831-842

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Expression of the murine Duchenne muscular dystrophy gene in muscle and brain

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

SH3 domain-mediated interaction of dystroglycan and Grb2

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Dystrophin and dystrophin-related proteins: a review of protein and RNA studies.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Becker muscular dystrophy with onset after 60 years.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Suppression of revertant fibers in mdx mice by expression of a functional dystrophin.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Prevalence of dystrophin-positive fibers in 85 Duchenne muscular dystrophy patients

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Somatic reversion/suppression of the mouse mdx phenotype in vivo.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Maintenance of an open reading frame as an additional level of scrutiny during splice site selection

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Boranophosphates as mimics of natural phosphodiesters in DNA.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Rationally targeted, conformationally constrained, oxetane-modified oligonucleotides demonstrate efficient gene-silencing activity in a cellular system

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Building oligonucleotide therapeutics using non-natural chemistries

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Morpholino antisense oligomers: design, preparation, and properties

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Listening to silence and understanding nonsense: exonic mutations that affect splicing

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Induction of revertant fibres in the mdx mouse using antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Targeted Disruption of Exon 52 in the Mouse Dystrophin Gene Induced Muscle Degeneration Similar to That Observed in Duchenne Muscular Dystrophy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Differential expression of dystrophin isoforms in strains of mdx mice with different mutations

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.6.831

21 January 2018

Identifiers

10.1517/14712598.7.6.831

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17555369%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34580135&oldid=1217407929"